The results showed that CXCL12 protein upregulated FOLR1 in HCC cells, and CAFs significantly increased secretion of FOLR1 in HCC cells; both of these phenotypes were associated with sorafenib resistance in HCC cells (Fig. 4d-i). Here, FOLR1 is linked to hepatocellular carcinoma.